stella
beta
Patient Relevant Outcomes Improvement Program in High Risk Hormone Receptor Positive (HR+) Breast Cancer — Stella
Home
/
HR+/HER2- Early Breast Cancer
/
View on ClinicalTrials.gov
Recruiting
Back to HR+/HER2- Early Breast Cancer trials
Trial locations
(1 site)
Germany
Department of Obstetrics and Gynaecology, Uniklinikum Erlangen, Erlangen, Bavaria